arrow
C

Claudia Trojaniello

istituto nazionale tumori irccs fondazione g pascale
H指数:18
被引数:1,095

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune Checkpoint Inhibitor Data in Metastatic Melanoma with Pre-Existing Autoimmune Disease: A Real World Experience

免疫检查点抑制剂在伴有预存自身免疫性疾病转移性黑色素瘤中的数据:一项真实世界研究

2026-10-030
OA
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

黑色素瘤新辅助治疗的五年生存率:国际黑色素瘤新辅助治疗协作组(INMC)更新的汇总分析

2026-10-010
OAAI
Lights and shadows of time-of-day administration of immune checkpoint inhibitors in solid tumors: a comprehensive review with exploratory analyses

实体肿瘤中免疫检查点抑制剂的时间给药策略的利弊:一项包含探索性分析的全面综述

2026-08-250
OA
Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy
2024-11-010
PRE
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
2024-01-012
PRE
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup
2023-07-015
PRE
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
2023-02-239
OAAI
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study

高危、可切除BRAF突变和野生型黑色素瘤患者的新辅助治疗联合辅助治疗或序贯vemurafenib、cobimetinib和阿特珠单抗: neo-tim,一项II期随机非对比研究

2023-02-091
OAAI
Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis

转移性黑色素瘤患者的Nivolumab血清浓度可能与预后和增强的免疫活性有关: 基因分析回顾性分析

2022-11-245
OAAI
IL-6 AS PROGNOSTIC FACTOR IN ADJUVANT OR METASTATIC SKIN CANCER PATIENTS TREATED WITH IMMUNOTHERAPY - A REAL LIFE STUDY
2022-11-070
OA
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma (vol 157, pg 250, 2021)
2022-05-010
OAAI
Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas
2022-01-1115
OAAI
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma
2021-11-0172
PREAI
The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysis
2021-07-0115
OAAI